Behner Peter 4

What Happened

• Peter Behner, a director of MiNK Therapeutics, received two restricted stock unit (RSU) awards as board/committee compensation: 1,491 RSUs on 2026-03-02 at an effective value of $10.90 each ($16,252) and 1,313 RSUs on 2026-06-01 at $12.38 each ($16,255). These are awards/acquisitions (A), not open-market purchases or sales.

Key Details

• Transaction dates and values:
  • 2026-03-02: 1,491 RSUs @ $10.90 = $16,252
  • 2026-06-01: 1,313 RSUs @ $12.38 = $16,255
• Total awarded: 2,804 RSUs, total value ≈ $32,507.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes:
  • F1: RSUs represent a contingent right to one share per RSU; these particular RSUs were granted in lieu of cash retainers and vest one month after each grant.
  • F2: The Q1 2026 RSU grant(s) were not filed timely due to an administrative error.
• Filing timeliness: Late filing (filed 2026-06-02 for a 2026-03-02 grant) — transactionTimeliness = 'L'.

Context

• RSU awards as director compensation are routine and reflect non-cash pay rather than an investment decision; they convert to shares on vesting (here, one month after each grant date).
• Because these are compensation awards (not purchases or sales), they should be interpreted as payroll-related, not necessarily as a bullish or bearish signal by the insider.